-+ 0.00%
-+ 0.00%
-+ 0.00%

MiMedx Group Inks $25M License Deal With Undisclosed Wound Care Competitor To Settle Allegations Of Infringement Of MiMedx's Patents

Benzinga·10/28/2026 20:03:33
Listen to the news

MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that it has entered into a license agreement with a wound care competitor that resolves allegations of infringement of MIMEDX’s patents.

Under the terms of the agreement:

  • The licensee will pay MIMEDX a total of $25 million in five equal installments of $5 million.
  • The first installment has been received, and the four remaining installments will be paid annually on the anniversary of the signing date.
  • MIMEDX has granted the licensee a non-exclusive license to the covered patents.